Pharmacological profile of YM348, a novel, potent and orally active 5-HT 2C receptor agonist

By Kimura Y.   Hatanaka K.-i.   Naitou Y.   Maeno K.   Shimada I.   Koakutsu A.   Wanibuchi F.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 37-43

Elsevier

Access to resources Recommend Favorite

Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT 3 receptor antagonist - a new animal model

By Ozaki A.   Sukamoto T.  

General Pharmacology, Vol. 33, Iss. 3, 1999-09 ,pp. : 283-288

Elsevier

Access to resources Recommend Favorite

Synthesis and pharmacological evaluation of novel 4-(4-fluorobenzoyl)piperidine derivatives as mixed 5-HT 1A /5-HT 2A /D 2 receptor ligands

By Diouf O.   Carato P.   Lesieur I.   Rettori M.C.   Caignard D.H.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 1, 1999-01 ,pp. : 69-73

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B 2 receptor antagonist, FR167344

By Inamura N.   Asano M.   Hatori C.   Sawai H.   Jiro Hirosumi   Fujiwara T.   Kayakiri H.   Satoh S.   Abe Y.   Inoue T.   Sawada Y.   Oku T.   Nakahara K.  

European Journal of Pharmacology, Vol. 333, Iss. 1, 1997-08 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite

9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT 2A receptor antagonist

By Westkaemper R.B.   Runyon S.P.   Bondarev M.L.   Savage J.E.   Roth B.L.   Glennon R.A.  

European Journal of Pharmacology, Vol. 380, Iss. 1, 1999-09 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite